Get the Stockscreener App
12.39
5.78%
-0.76
Shoulder Innovations Inc stock is traded at $12.39, with a volume of 45,917.
It is down -5.78% in the last 24 hours and down -2.75% over the past month.
Shoulder Innovations Inc is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. It currently offers advanced implant systems for shoulder arthroplasty. Its products include: InSet Total Shoulder Arthroplasty; InSet Reverse Shoulder Arthroplasty; ProVoyance Shoulder Planning Software; and InSet Tray System.
See More
Previous Close:
$13.15
Open:
$13
24h Volume:
45,917
Relative Volume:
0.31
Market Cap:
$252.26M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-0.4136
EPS:
-29.96
Net Cash Flow:
-
1W Performance:
+1.64%
1M Performance:
-2.75%
6M Performance:
+883.41%
1Y Performance:
+883.41%
1-Day Range:
$12.39
$13.23
1-Week Range:
$12.20
$13.70
52-Week Range:
$11.51
$17.94
Shoulder Innovations Inc Stock (SI) Company Profile
Name
Shoulder Innovations Inc
Sector
Industry
Phone
616-566-0286
Address
13827 PORT SHELDON STREET, HOLLAND
Compare SI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SI
Shoulder Innovations Inc
|
12.39 | 267.73M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
132.57 | 232.02B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
95.41 | 144.14B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.60 | 141.53B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.45 | 123.78B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.94 | 44.14B | 5.69B | 1.41B | 577.90M | 6.9828 |
Shoulder Innovations Inc Stock (SI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-25-25 | Initiated | BTIG Research | Buy |
| Aug-25-25 | Initiated | Goldman | Buy |
| Aug-25-25 | Initiated | Jefferies | Buy |
| Aug-25-25 | Initiated | Piper Sandler | Overweight |
| Mar-06-23 | Downgrade | Compass Point | Neutral → Sell |
| Mar-06-23 | Downgrade | Wedbush | Neutral → Underperform |
| Mar-02-23 | Downgrade | Canaccord Genuity | Buy → Hold |
| Mar-02-23 | Downgrade | Compass Point | Buy → Neutral |
| Mar-02-23 | Downgrade | JP Morgan | Neutral → Underweight |
| Mar-01-23 | Downgrade | Keefe Bruyette | Outperform → Mkt Perform |
| Jan-09-23 | Downgrade | Wedbush | Outperform → Neutral |
| Jan-06-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Jan-06-23 | Downgrade | Craig Hallum | Buy → Hold |
| Jan-06-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-12-22 | Reiterated | Wedbush | Outperform |
| Dec-05-22 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Nov-21-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Nov-10-22 | Downgrade | BofA Securities | Buy → Neutral |
| Oct-26-22 | Downgrade | Goldman | Buy → Neutral |
| Oct-06-22 | Downgrade | Wells Fargo | Overweight → Underweight |
| Aug-04-22 | Initiated | BTIG Research | Buy |
| Jun-13-22 | Initiated | Wells Fargo | Overweight |
| Jun-09-22 | Resumed | Morgan Stanley | Equal-Weight |
| Mar-21-22 | Initiated | BofA Securities | Buy |
| Jan-20-22 | Upgrade | Goldman | Neutral → Buy |
| Dec-16-21 | Initiated | B. Riley Securities | Buy |
| Nov-11-21 | Initiated | JP Morgan | Overweight |
| Nov-08-21 | Downgrade | Keefe Bruyette | Outperform → Mkt Perform |
| Sep-27-21 | Initiated | Morgan Stanley | Overweight |
| Jun-14-21 | Initiated | Goldman | Neutral |
| Jan-14-21 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-22-20 | Initiated | Wedbush | Outperform |
| Dec-17-20 | Upgrade | Keefe Bruyette | Mkt Perform → Outperform |
| Dec-02-20 | Initiated | Craig Hallum | Buy |
| Oct-16-20 | Initiated | Compass Point | Buy |
| Mar-16-20 | Initiated | Canaccord Genuity | Buy |
| Dec-03-19 | Initiated | Keefe Bruyette | Mkt Perform |
| Dec-02-19 | Initiated | Barclays | Overweight |
| Nov-18-19 | Initiated | Compass Point | Buy |
View All
Shoulder Innovations Inc Stock (SI) Latest News
Head-To-Head Survey: Bioventus (NASDAQ:BVS) & Shoulder Innovations (NYSE:SI) - Defense World
Is Shoulder Innovations Inc. stock considered safe havenEarnings Miss & Stock Portfolio Risk Management - newser.com
Is Shoulder Innovations Inc. stock protected from inflationPortfolio Update Summary & Pattern Based Trade Signal System - newser.com
Is Shoulder Innovations Inc. stock worth holding before Fed meetingJuly 2025 Summary & Daily Stock Momentum Reports - newser.com
Shoulder Replacement in the United States: Geriatric & Sports - openPR.com
Shoulder Innovations (NYSE:SI) Cut to Sell at Wall Street Zen - Defense World
User - FinancialContent
Shoulder Innovations Stock Jumps 8% On NYSE Debut - MSN
Brokerages Set Shoulder Innovations, Inc. (NYSE:SI) Target Price at $19.60 - Defense World
Shoulder Innovations, Inc. (NYSE:SI) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Shoulder Innovations launches new humeral stem implant nationwide By Investing.com - Investing.com Canada
Shoulder Innovations Launches InSet 70 Humeral Stem to Expand I-Series Product Line - geneonline.com
Shoulder Innovations launches new humeral stem implant nationwide - Investing.com
Bone-Preserving InSet 70 Shoulder Implant: Shoulder Innovations' Latest Innovation for Arthritis Treatment - Stock Titan
Shoulder Innovations (NYSE:SI) CEO Robert Joseph Ball Acquires 6,000 Shares - MarketBeat
Shoulder Innovations (NYSE:SI) Upgraded to "Hold" at Wall Street Zen - MarketBeat
Insider Buying: Shoulder Innovations (NYSE:SI) CEO Purchases 2,000 Shares of Stock - MarketBeat
Insider Buying: Shoulder Innovations (NYSE:SI) CFO Buys 1,600 Shares of Stock - MarketBeat
Top Executives Make Bold Moves with Major Stock Purchases at Shoulder Innovations! - TipRanks
Insider Buying: Robert Ball Acquires Additional Shares of Should - GuruFocus
Zai Lab Limited ADR (NASDAQ: ZLAB) Is Up 14.37% – Is It Capable Of A Rally? - stocksregister.com
Shoulder Innovations (NYSE:SI) Announces Earnings Results, Misses Estimates By $63.95 EPS - MarketBeat
Shoulder Innovations Inc (NYSE: SI) – Analysts’ Revisions Show Sentiment Is Improving - stocksregister.com
Shoulder Innovations (NYSE:SI) Receives "Buy" Rating from BTIG Research - MarketBeat
US-based Shoulder Innovations revenue up 33% to USD 11M in Q2 2025 - Medical Buyer
Analysts Offer Insights on NA Companies: Reddit Inc Class A (RDDT), Solventum Corporation (SOLV) and CG Oncology, Inc. (CGON) - The Globe and Mail
Shoulder Innovations revenue up 33% to USD 11M in Q2 2025 - Medical Buyer
Shoulder Innovations Inc Stock (SI) Financials Data
There is no financial data for Shoulder Innovations Inc (SI). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.83%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):